Laboratorios Richmond S.A.C.I.F

Short Term Long Term Short Term Comparison Long Term Comparison
  • RICH
  • 1d-1.13%
  • 1w4.45%
  • 1m14.39%
  • 1y145.72%
ATH
  • ATH Price$1,158.50
  • ATH Date2024-01-25
  • % since ATH-16.96%
  • % to ATH20.43%
ATL
  • ATL Price$25.54
  • ATL Date2018-06-29
  • % from ATL3,666.07%
  • Last Low Price$777.5
  • Last Low Date2024-03-11
  • % From Last Low23.73%
IPO
  • IPO Price$32.05
  • % Current ROI USD3,001.56%
  • ATH Price$1,158.50
  • % ROI ATH 453,532.94%
[addtoany]

Graph takes few seconds to load...

[financial_chart symbol="RICH"]

Key Data [addtoany]

Current price $962
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Today's High/Low $0/$0
Volume 0.00
Previous Close $973
52 Week High/Low $1235/$394
Market Cap 77,682,950,144.00
P/E Ratio 599.377
Forward P/E 1 Yr. $0.00
Earnings Per Share(EPS) $0
Annualized Dividend $0
$962
[addtoany]

Laboratorios Richmond S.A.C.I.F., a pharmaceutical company, develops and manufactures pharmaceutical products. It provides antivirals for the treatment of HIV and HCV; oncology and oncohematology drugs; cardiometabolic drugs, including antihypertensive, cholesterol-lowering, and anti platelet drugs; and psychiatric drugs comprising analgesic, anti psychotic, anti depressive, anti dementia, and hypnotic drugs, as well as drugs for the treatment of multiple sclerosis.
The company sells its products in Latin America, Africa, Asia, and the Middle East. Laboratorios Richmond S.A.C.I.F. was founded in 1935 and is based in Buenos Aires, Argentina.

Annual Data | Millions of US $ except per share data 2019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-09-302007-09-302006-09-30
Cash on hand --------------
Receivables $1,670.18$564.83$406.35$498.25$267.09$192.55$111.64$96.36$46.02$35.82$31.01$24.88$24.72$16.28
Inventory $930.91$530.62$287.84$189.79$142.14$94.69-$65.46$48.44$37.33$33.10$27.78$23$17.21
Pre-Paid Expenses --------------
Other Current Assets -$150.08$19.18$14.67$4.55--$0.50$0.61$0.95$13.31$15.25$0.89$0.92
Total Current Assets $3,287.66$1,967.31$1,353.68$726.58$430.71---------
Property, Plant, And Equipment $1,196.28$590.65$269.92$58.31$55.32$54.53-$52.50$44.80$38$22.92$22.08$20.34$13.13
Long-Term Investments $4.22$11.69$67.39$23.64$0.01---------
Goodwill And Intangible Assets $245.93$143.67$32.34$31.42$31.42$29.63-$40.44------
Other Long-Term Assets $392.55$300.53$62.03$21.18$15.37$7.70$83.99$6.71$4.35$3.77$2.25$0.90$0.47$3.45
Total Long-Term Assets $1,846.96$737.88$198.96-----------
Total Assets $5,134.62$2,705.19$1,552.64$861.13$532.83$385.66$287.37$270.96$159.03$135.78$127.84$100.63$77.58$56.36
Total Current Liabilities $2,475.95$1,250.10$748.42$546.95$337.70$239.85$153.56$132.79$70.89$49.93$50.44$51.41$32.07$36.24
Long Term Debt $150.04$96.36$25.70$23.42$32.61$10.12$15.78$21.82$8.53$11.76$3.62$1.68$3.25-
Other Non-Current Liabilities $364.55$381.18$196.17$101.30$66.40$39.61$27$24.03$29.41$29.17$19.33$18.25$29.02$12.37
Total Long Term Liabilities $558.71$344.16$116.17-----------
Total Liabilities $3,034.66$1,594.26$864.59$671.67$436.71$292.64$196.34$178.94$108.92$90.96$74.11$71.34$64.33$48.61
Common Stock Net $80.75$80.75$80.75$27.25$27.25$27.25$66.58$27.25$27.25$27.25$3.64$2.82$2.82$0.13
Retained Earnings (Accumulated Deficit) $-254.94$-241.42$40.70$122.88$29.54$26.43$24.45$25.37$22.86$17.56$14.52$10.97$10.42$7.43
Comprehensive Income --------------
Other Share Holders Equity $846.33$529.81$288.79-----------
Share Holder Equity $2,050.21$1,051.30$688.05$150.13$56.79$93.02$91.04$91.95$50.11$44.82$53.73$29.29$13.25$7.75
Total Liabilities And Share Holders Equity --------------